Zinc: The brain's dark horse

Synapse

Volumn 63, Issue 11, 2009, Pages 1029-1049

  Bitanihirwe, Byron K Y ^a   Cunningham, Miles G ^b,c  

^a ETH ZURICH   (Switzerland)

^b MCLEAN HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Central nervous system; Gluzinergic neuron; Neurological disease; Zinc; Zinc homeostasis

Indexed keywords

EDETATE CALCIUM; NEUROTOXIN; ZINC;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; BRAIN CORTEX; BRAIN DEVELOPMENT; BRAIN ISCHEMIA; CENTRAL NERVOUS SYSTEM FUNCTION; CYTOLOGY; DEPRESSION; EPILEPSY; HUMAN; ISCHEMIA; NERVE CELL PLASTICITY; NEUROLOGIC DISEASE; NEUROMODULATION; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SCHIZOPHRENIA; SYNAPSE VESICLE; SYNAPTIC TRANSMISSION;

ANIMALS; BRAIN; BRAIN DISEASES; HUMANS; TRACE ELEMENTS; ZINC;

EID: 70349292938     PISSN: 08874476     EISSN: 10982396     Source Type: Journal    
DOI: 10.1002/syn.20683     Document Type: Review

References (441)

1. Acarin L, González B, Hidalgo J, Castro AJ, Castellano B. 1999. Primary cortical glial reaction versus secondary thalamic glial response in the excitotoxically injured young brain: Astroglial response and metallothionein expression. Neuroscience 92:827-839. (Pubitemid 29287530)
2. Age-Related Eye Disease Study Research Group. 2001. A randomized, placebo-controlled, clinical trial of high dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss. AREDS Report No. 8. Arch Opthalmol 119:1417-1436.
3. Aiuchi T, Mihara S, Nakaya M, Masuda Y, Nakajo S, Nakaya K. 1998. Zinc ions prevent processing of caspase-3 during apoptosis induced by geranylgeraniol in HL-60 cells. J Biochem 124:300-303. (Pubitemid 28419673)
4. Akbarian S, Kim JJ, Potkin SG, Hagman JO, Tafazzoli A, Bunney WE Jr, Jones EG. 1995. Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics. Arch Gen Psychiatry 52:258-266.
5. Alpers DH. 1994. Zinc and deficiencies of taste and smell. JAMA 272:1233-1234.
6. Andrasi E, Farkas E, Gawlik D, Rosick U, Bratter P. 2000. Brain iron and zinc contents of german patients with alzheimer disease. J Alzheimers Dis 2:17-26. (Pubitemid 30353514)
7. Arseniev A, Schultze P, Wörgötter E, Braun W, Wagner G, Vasák M, Kägi JH, Wü thrich K. 1988. Three-dimensional structure of rabbit liver [Cd7]metallothionein-2a in aqueous solution determined by nuclear magnetic resonance. J Mol Biol 201:637-657.
8. Aschner M. 1997. Astrocyte metallothioneins (MTs) and their neuroprotective role. Ann N Y Acad Sci 825:334-347. (Pubitemid 27503728)
9. Assaf SY, Chung SH. 1984. Release of endogenous Zn2+ from brain tissue during activity. Nature 308:734-736. (Pubitemid 14127670)
10. Azriel-Tamir H, Sharir H, Schwartz B, Hershfinkel M. 2004. Extracellular zinc triggers ERK-dependent activation of Na+/H+ exchange in colonocytes mediated by the zinc-sensing receptor. J Biol Chem 279:51804-51816. (Pubitemid 39656547)
11. 2+. Brain Res 557:103-108.
12. Bao B, Prasad AS, Beck FW, Godmere M. 2003. Zinc modulates mRNA levels of cytokines. Am J Physiol Endocrinol Metab 285:E1095-E1102. (Pubitemid 37296332)
13. Barthel A, Ostrakhovitch EA, Walter PL, Kampkötter A, Klotz LO. 2007. Stimulation of phosphoinositide 3-kinase/Akt signaling by copper and zinc ions: mechanisms and consequences. Arch Biochem Biophys 463:175-182. (Pubitemid 47030342)
14. Barañano DE, Ferris CD, Snyder SH. 2001. Atypical neural messengers. Trends Neurosci 24:99-106.
15. Beaulieu C, Dyck R, Cynader M. 1992. Enrichment of glutamate in zinc-containing terminals of the cat visual cortex. Neuroreport 3:861-864.
16. Benes FM. 1995. Altered glutamatergic and GABAergic mechanisms in the cingulate cortex of the schizophrenic brain. Arch Gen Psychiatry 52:1015-1018.
17. Benes FM. 2000. Emerging principles of altered neural circuitry in schizophrenia. Brain Res Brain Res Rev 31:251-269.
18. Benes FM, McSparren J, Bird ED, SanGiovanni JP, Vincent SL. 1991. Deficits in small interneurons in prefrontal and cingulate cortices of schizophrenic and schizoaffective patients. Arch Gen Psychiatry 48:996-1001.
19. Benes FM, Sorensen I, Vincent SL, Bird ED, Sathi M. 1992. Increased density of glutamate-immunoreactive vertical processes in superficial laminae in cingulate cortex of schizophrenic brain. Cereb Cortex 2:503-512.
20. Benes FM, Lim B,Matzilevich D,Walsh JP, Subburaju S,Minns M. 2007. Regulation of the GABA cell phenotype in hippocampus of schiyophrenics and bipolars. Proc Natl Acad Sci USA 104:10164-10169.
21. Bennett MV, Pellegrini-Giampietro DE, Gorter JA, Aronica E, Connor JA, Zukin RS. 1996. The GluR2 hypothesis: Ca(++)-permeable AMPA receptors in delayed neurodegeneration. Cold Spring Harb Symp Quant Biol 61:373-384. (Pubitemid 27257986)
22. Bhatnagar S, Taneja S. 2001. Zinc and cognitive development. Br J Nutr 85(Suppl 2):S139-S145.
23. Bhatnagar S, Natchu UC. 2004. Zinc in child health and disease. Indian J Pediatr 71:991-995.
24. Billings LM, Oddo S, Green KN, McGaugh JL, LaFerla FM. 2005. Intraneuronal Abeta causes the onset of early Alzheimer's disease-related cognitive deficits in transgenic mice. Neuron 45:675-688. (Pubitemid 40320703)
25. Blaauwgeers HG, Anwar Chand M, van den Berg FM, Vianney de Jong JM, Troost D. 1996. Expression of different metallothionein messenger ribonucleic acids in motor cortex, spinal cord and liver from patients with amyotrophic lateral sclerosis. J Neurol Sci 142:39-44. (Pubitemid 26340407)
26. Black MM. 1998. Zinc deficiency and child development. Am J Clin Nutr 68(2 Suppl):464S-469S.
27. Black MM. 2003a. The evidence linking zinc deficiency with children's cognitive andmotor functioning. J Nutr 133(5 Suppl 1): 1473S-1476S.
28. Black MM. 2003b. Micronutrient deficiencies and cognitive functioning. J Nutr 133(11 Suppl 2):3927S-3931S.
29. Blasco-Ibáñez JM, Poza-Aznar J, Crespo C, Marqués-Marí AI, Gracia-Llanes FJ, Martínez-Guijarro FJ. 2004. Chelation of synaptic zinc induces overexcitation in the hilar mossy cells of the rat hippocampus. Neurosci Lett 355:101-104.
30. Bochet P, Audinat E, Lambolez B, Crépel F, Rossier J, Iino M, Tsuzuki K, Ozawa S. 1994. Subunit composition at the single-cell level explains functional properties of a glutamate-gated channel. Neuron 12:383-388. (Pubitemid 24071302)
31. Bonanni L, Chachar M, Jover-Mengual T, Li H, Jones A, Yokota H, Ofengeim D, Flannery RJ, Miyawaki T, Cho CH, Polster BM, Pypaert M, Hardwick JM, Sensi SL, Zukin RS, Jonas EA. 2006. Zinc-dependent multi-conductance channel activity in mitochondria isolated from ischemic brain. J Neurosci 26:6851-6862. (Pubitemid 44315246)
32. Bray TM, Bettger WJ. 1990. The physiological role of zinc as an antioxidant. Free Radic Biol Med 8:281-291.
33. Brown CE, Dyck RH. 2002. Rapid, experience-dependent changes in levels of synaptic zinc in primary somatosensory cortex of the adult mouse. J Neurosci 22:2617-2625.
34. Brown CE, Dyck RH. 2003a. Experience-dependent regulation of synaptic zinc is impaired in the cortex of aged mice. Neuroscience 119:795-801. (Pubitemid 36694806)
35. Brown CE, Dyck RH. 2003b. An improved method for visualizing the cell bodies of zincergic neurons. J Neurosci Methods 129:41-47.
36. Brown CE, Dyck RH. 2004. Distribution of zincergic neurons in the mouse forebrain. J Comp Neurol 479:156-167.
37. Brown CE, Dyck RH. 2005. Modulation of synaptic zinc in barrel cortex by whisker stimulation. Neuroscience 134:355-359.
38. Brown AM, Kristal BS, Effron MS, Shestopalov AI, Ullucci PA, Sheu KF, Blass JP, Cooper AJ. 2000. Zn21 inhibits alpha-ketoglutarate-stimulated mitochondrial respiration and the isolated alpha-ketoglutarate dehydrogenase complex. J Biol Chem 275:13441-13447.
39. Buhl EH, Otis TS, Mody I. 1996. Zinc-induced collapse of augmented inhibition by GABA in a temporal lobe epilepsy model. Science 271:369-373. (Pubitemid 3021514)
40. Burgard EC, Tietz EI, Neelands TR, Macdonald RL. 1996. Properties of recombinant gamma-aminobutyric acid A receptor isoforms containing the alpha 5 subunit subtype. Mol Pharmacol 50:119-127.
41. Bush AI. 2000. Metals and neuroscience. Curr Opin Chem Biol 4:184-191.
42. Bush AI, Multhaup G, Moir RD, Williamson TG, Small DH, Rumble B, Pollwein P, Beyreuther K, Masters CL. 1993. A novel zinc(II) binding site modulates the function of the beta A4 amyloid protein precursor of Alzheimer's disease. J Biol Chem 268:16109-16112. (Pubitemid 23229904)
43. Calderone A, Jover T, Noh KM, Tanaka H, Yokota H, Lin Y, Grooms SY, Regis R, Bennett MV, Zukin RS. 2003. Ischemic insults derepress the gene silencer REST in neurons destined to die. J Neurosci 23:2112-2121. (Pubitemid 36368899)
44. Calderone A, Jover T, Mashiko T, Noh KM, Tanaka H, Bennett MV, Zukin RS. 2004. Late calcium EDTA rescues hippocampal CA1 neurons from global ischemia-induced death. J Neurosci 24:9903-9913. (Pubitemid 39463571)
45. Carrasco J, Penkowa M, Hadberg H, Molinero A, Hidalgo J. 2000. Enhanced seizures and hippocampal neurodegeneration following kainic acid-induced seizures in metallothionein-I + II-deficient mice. Eur J Neurosci 12:2311-2322. (Pubitemid 30497029)
46. Carriedo SG, Yin HZ, Sensi SL, Weiss JH. 1998. Rapid Ca2+ entry through Ca2+-permeable AMPA/Kainate channels triggers marked intracellular Ca2+ rises and consequent oxygen radical production. J Neurosci 18:7727-7738.
47. Casanovas-Aguilar C, Christensen MK, Reblet C, Martínez- García F, Pérez-Clausell J, Bueno-López JL. 1995. Callosal neurones give rise to zinc-rich boutons in the rat visual cortex. Neuroreport 6:497-500.
48. Casanovas-Aguilar C, Reblet C, Pérez-Clausell J, Bueno-López JL. 1998. Zinc-rich afferents to the rat neocortex: Projections to the visual cortex traced with intracerebral selenite injections. J Chem Neuroanat 15:97-109. (Pubitemid 28389060)
49. Casanovas-Aguilar C, Miró-Bernié N, Pérez-Clausell J. 2002. Zincrich neurones in the rat visual cortex give rise to two laminar segregated systems of connections. Neuroscience 110:445-458. (Pubitemid 34242774)
50. Castrén E. 2004. Neurotrophins as mediators of drug effects on mood, addiction, and neuroprotection. Mol Neurobiol 29:289-302. (Pubitemid 41359112)
51. Chai F, Truong-Tran AQ, Ho LH, Zalewski PD. 1999. Regulation of caspase activation and apoptosis by cellular zinc fluxes and zinc deprivation: A review. Immunol Cell Biol 77:272-278. (Pubitemid 29251581)
52. Chan MK, Othman R, Zubir D, Salmijah S. 2002. Induction of a putative metallothionein gene in the blood cockle. Anadara granosa, exposed to cadmium. Comp Biochem. Physiol Toxicol Pharmacol 131:123-132.
53. Chen B, Dowlatshahi D, MacQueen GM, Wang JF, Young LT. 2001. Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication. Biol Psychiatry 50:260-265. (Pubitemid 32778442)
54. Chechlacz M, Gleeson JG. 2003. Is mental retardation a defect of synapse structure and function? Pediatr Neurol 29:11-17.
55. Cherny RA, Legg JT, McLean CA, Fairlie DP, Huang X, Atwood CS, Beyreuther K, Tanzi RE, Masters CL, Bush AI. 1999. Aqueous dissolution of Alzheimer's disease Abeta amyloid deposits by biometal depletion. J Biol Chem 274:23223-23228. (Pubitemid 129529155)
56. Cherny RA, Atwood CS, Xilinas ME, Gray DN, Jones WD, McLean CA, Barnham KJ, Volitakis I, Fraser FW, Kim Y, Huang X, Goldstein LE, Moir RD, Lim JT, Beyreuther K, Zheng H, Tanzi RE, Masters CL, Bush AI. 2001. Treatment with a copper-zinc chelator markedly and rapidly inhibits beta-amyloid accumulation in Alzheimer's disease transgenic mice. Neuron 30:665-676. (Pubitemid 32607332)
57. Chimienti F, Devergnas S, Favier A, Seve M. 2004. Identification and cloning of a beta-cell-specific zinc transporter. ZnT-8, localized into insulin secretory granules. Diabetes 53:2330-2337.
58. Choi DW. 1996. Zinc neurotoxicity may contribute to selective neuronal death following transient global cerebral ischemia. Cold Spring Harb Symp Quant Biol 61:385-387. (Pubitemid 27257987)
59. Chou SS, Clegg MS, Momma TY, Niles BJ, Duffy JY, Daston GP, Keen CL. 2004. Alterations in protein kinase C activity and processing during zinc-deficiency-induced cell death. Biochem J 383:63-71. (Pubitemid 39389451)
60. Christensen MK, Geneser FA. 1995. Distribution of neurons of origin of zinc-containing projections in the amygdala of the rat. Anat Embryol 191:227-237.
61. Christensen MK, Frederickson CJ. 1998. Zinc-containing afferent projections to the rat corticomedial amygdaloid complex: A retrograde tracing study. J Comp Neurol 400:375-390.
62. Christensen MK, Frederickson CJ, Danscher G. 1992. Retrograde tracing of zinc-containing neurons by selenide ions: A survey of seven selenium compounds. J Histochem Cytochem 40:575-579.
63. Cieślik K, Klenk-Majewska B, Danilczuk Z, Wróbel A, Lupina T, Ossowska G. 2007. Influence of zinc supplementation on imipramine effect in a chronic unpredictable stress (CUS) model in rats. Pharmacol Rep 59:46-52. (Pubitemid 46522701)
64. Clegg MS, Hanna LA, Niles BJ, Momma TY, Keen CL. 2005. Zinc deficiency-induced cell death. Life 57:661-669.
65. Cohen-Kfir E, Lee W, Eskandari S, Nelson N. 2005. Zinc inhibition of gamma-aminobutyric acid transporter 4 (GAT4) reveals a link between excitatory and inhibitory neurotransmission. Proc Natl Acad Sci USA 102:6154-6159. (Pubitemid 40594271)
66. Cole TB, Wenzel HJ, Kafer KE, Schwartzkroin PA, Palmiter RD. 1999. Elimination of zinc from synaptic vesicles in the intact mouse brain by disruption of the ZnT3 gene. Proc Natl Acad Sci USA 96:1716-1721.
67. Cole TB, Robbins CA, Wenzel HJ, Schwartzkroin PA, Palmiter RD. 2000. Seizures and neuronal damage in mice lacking vesicular zinc. Epilepsy Res 39:153-169.
68. Cole TB, Martyanova A, Palmiter RD. 2001. Removing zinc from synaptic vesicles does not impair spatial learning, memory, or sensorimotor functions in the mouse. Brain Res 891:253-265. (Pubitemid 32115515)
69. Coleman JE. 1992. Zinc proteins: enzymes, storage proteins, transcription factors, and replication proteins. Annu Rev Biochem 61:897-946.
70. Colvin RA, Fontaine CP, Laskowski M, Thomas D. 2003. Zn2+ transporters and Zn2+ homeostasis in neurons. Eur J Pharmacol 479:171-185.
71. Colvin RA, Bush AI, Volitakis I, Fontaine CP, Thomas D, Kikuchi K, Holmes WR. 2008. Insights into Zn2+ homeostasis in neurons from experimental and modeling studies. Am J Physiol Cell Physiol 294:C726-C742.
72. Cornett CR, Markesbery WR, Ehmann WD. 1998. Imbalances of trace elements related to oxidative damage in Alzheimer's disease brain. Neurotoxicology 19:339-345.
73. Corrigan FM, Reynolds GP, Ward NI. 1993. Hippocampal tin, aluminum and zinc in Alzheimer's disease. Biometals 6:149-154.
74. Coulter DA. 2000. Mossy fiber zinc and temporal lobe epilepsy: Pathological association with altered "epileptic" gamma-aminobutyric acid A receptors in dentate granule cells. Epilepsia 41 (Suppl 6):S96-S99.
75. Cousins RJ. 1998. A role of zinc in the regulation of gene expression. Proc Nutr Soc 57:307-311. (Pubitemid 128737057)
76. Cousins RJ, Liuzzi JP, Lichten LA. 2006. Mammalian zinc transport, trafficking, and signals. J Biol Chem 281:24085-24089.
77. Coyle JT, Puttfarcken P. 1993. Oxidative stress, glutamate, and neurodegenerative disorders. Science 262:689-695. (Pubitemid 23350687)
78. Cragg RA, Christie GR, Phillips SR, Russi RM, Küry S, Mathers JC, Taylor PM, Ford D. 2002. A novel zinc-regulated human zinc transporter, hZTL1, is localized to the enterocyte apical membrane. J Biol Chem 277:22789-22797. (Pubitemid 34967259)
79. Crossthwaite AJ, Hasan S, Williams RJ. 2002. Hydrogen peroxide-mediated phosphorylation of ERK1/2. Akt/PKB and JNK in cortical neurones: Dependence on Ca(2+) and PI3-kinase. J Neurochem 80:24-35. (Pubitemid 34614574)
80. Crow JP, Sampson JB, Zhuang Y, Thompson JA, Beckman JS. 1997. Decreased zinc affinity of amyotrophic lateral sclerosis-associated superoxide dismutase mutants leads to enhanced catalysis of tyrosine nitration by peroxynitrite. J Neurochem 69:1936-1944. (Pubitemid 27452740)
81. Cuajungco MP, Lees GJ. 1997. Zinc and Alzheimer's disease: Is there a direct link? Brain Res Rev 23:219-236.
82. Cuajungco MP, Faget KY. 2003. Zinc takes the center stage: Its paradoxical role in Alzheimer's disease. Brain Res Brain Res Rev 41:44-56.
83. Cunningham MG, Ames HM, Christensen MK, Sorensen JC. 2007. Zincergic innervation of medial prefrontal cortex by basolateral projection neurons. Neuroreport 18:531-535.
84. Danscher G, Howell G, Pérez-Clausell J, Hertel N. 1985. The dithizone. Timm's sulphide silver and the selenium methods demonstrate a chelatable pool of zinc in CNS. A proton activation (PIXE) analysis of carbon tetrachloride extracts from rat brains and spinal cords intravitally treated with dithizone. Histochemistry 83:419-422.
85. Danscher G, Jensen KB, Frederickson CJ, Kemp K, Andreasen A, Juhl S, Stoltenberg M, Ravid R. 1997. Increased amount of zinc in the hippocampus and amygdala of Alzheimer's diseased brains: A proton-induced X-ray emission spectroscopic analysis of cryostat sections from autopsy material. J Neurosci Methods 76:53-59. (Pubitemid 27405086)
86. Danscher G, Wang Z, Kim YK, Kim SJ, Sun Y, Jo SM. 2003. Immunocytochemical localization of zinc transporter 3 in the ependyma of the mouse spinal cord. Neurosci Lett 342:81-84. (Pubitemid 36513915)
87. Daumas S, Halley H, Lassalle JM. 2004. Disruption of hippocampal CA3 network: Effects on episodic-like memory processing in C57BL/6J mice. Eur J Neurosci 20:597-600. (Pubitemid 38969647)
88. Davis SR, Cousins RJ. 2000. Metallothionein expression in animals: A physiological perspective on function. J Nutr 130:1085-1088.
89. Deibel MA, Ehmann WD, Markesbery WR. 1996. Copper, iron, and zinc imbalances in severely degenerated brain regions in Alzheimer's disease: Possible relation to oxidative stress. J Neurol Sci 143:137-142.
90. Dineley KE, Votyakova TV, Reynolds IJ. 2003. Zinc inhibition of cellular energy production: Implications for mitochondria and neurodegeneration. J Neurochem 85:563-570.
91. Dineley KE, Richards LL, Votyakova TV, Reynolds IJ. 2005. Zinc causes loss of membrane potential and elevates reactive oxygen species in rat brain mitochondria. Mitochondrion 5:55-65.
92. Dominguez MI, Blasco-Ibanez JM, Crespo C, Marques-Mari AI, Martinez-Guijarro FJ. 2003. Zinc chelation during non-lesioning overexcitation results in neuronal death in the mouse hippocampus. Neuroscience 116:791-806. (Pubitemid 36160574)
93. Dong J, Atwood CS, Anderson VE, Siedlak SL, Smith MA, Perry G, Carey PR. 2003. Metal binding and oxidation of amyloid-beta within isolated senile plaque cores: Raman microscopic evidence. Biochemistry 42:2768-2773. (Pubitemid 36331519)
94. Doraiswamy PM, Finefrock AE. 2004. Metals in our minds: Therapeutic implications for neurodegenerative disorders. Lancet Neurol 3:431-434. (Pubitemid 38789138)
95. 2+ Neuron 5:781-788.
96. Drevets WC, Price JL, Furey ML. 2008. Brain structural and functional abnormalities in mood disorders: Implications for neurocircuitry models of depression. Brain Struct Funct 213:93-118.
97. Dudek FE. 2001. Zinc and epileptogenesis. Epilepsy Curr 1:66-70.
98. Duff K, Eckman C, Zehr C, Yu X, Prada CM, Perez-tur J, Hutton M, Buee L, Harigaya Y, Yager D, Morgan D, Gordon MN, Holcomb L, Refolo L, Zenk B, Hardy J, Younkin S. 1996. Increased amyloid-beta42(43) in brains of mice expressing mutant presenilin 1. Nature 383:710-713. (Pubitemid 26360645)
99. Duman RS, Heninger GR, Nestler EJ. 1997. A molecular and cellular theory of depression. Arch Gen Psychiatry 54:597-606.
100. Dvergsten CL, Fosmire GJ, Ollerich DA, Sandstead HH. 1983. Alterations in the postnatal development of the cerebellar cortex due to zinc deficiency. I. Impaired acquisition of granule cells. Brain Res 271:217-226.
101. Dvergsten CL, Johnson LA, Sandstead HH. 1984a. Alterations in the postnatal development of the cerebellar cortex due to zinc deficiency. III. Impaired dendritic differentiation of basket and stellate cells. Brain Res 318:21-26.
102. Dvergsten CL, Fosmire GJ, Ollerich DA, Sandstead HH. 1984b. Alterations in the postnatal development of the cerebellar cortex due to zinc deficiency. II. Impaired maturation of Purkinje cells. Brain Res 318:11-20.
103. Dyck R, Beaulieu C, Cynader M. 1993. Histochemical localization of synaptic zinc in the developing cat visual cortex. J Comp Neurol 329:53-67. (Pubitemid 23078221)
104. Ebadi M, Murrin LC, Pfeiffer RF. 1990. Hippocampal zinc thionein and pyridoxal phosphate modulate synaptic functions. Ann N Y Acad Sci 585:189-201. (Pubitemid 20175897)
105. Eide DJ. 2004. The SLC39 family of metal ion transporters. Pflugers Arch 447:796-800.
106. Eide DJ. 2006. Zinc transportzers and the cellular trafficking of zinc. Biochim Biophys Acta 1763:711-722.
107. Emerit J, Edeas M, Bricaire F. 2004. Neurodegenerative diseases and oxidative stress. Biomed Pharmacother 58:39-46.
108. Erickson JC, Hollopeter G, Thomas SA, Froelick GJ, Palmiter RD. 1997. Disruption of the metallothionein-III gene in mice: Analysis of brain zinc, behavior, and neuron vulnerability to metals, aging, and seizures. J Neurosci 17:1271-1281. (Pubitemid 27073729)
109. Ermilova IP, Ermilov VB, Levy M, Ho E, Pereira C, Beckman JS. 2005. Protection by dietary zinc in ALS mutant G93A SOD transgenic mice. Neurosci Lett 379:42-46. (Pubitemid 40462395)
110. Estévez AG, Crow JP, Sampson JB, Reiter C, Zhuang Y, Richardson GJ, Tarpey MM, Barbeito L, Beckman JS. 1999. Induction of nitric oxide-dependent apoptosis in motor neurons by zinc-deficient superoxide dismutase. Science 286:2498-2500. (Pubitemid 30026336)
111. Fisher JL. 2002. A histidine residue in the extracellular N-terminal domain of the GABA(A) receptor alpha5 subunit regulates sensitivity to inhibition by zinc. Neuropharmacology 42:922-928. (Pubitemid 34628623)
112. Fisher JL, Macdonald RL. 1998. The role of an alpha subtype M2-M3 His in regulating inhibition of GABAA receptor current by zinc and other divalent cations. J Neurosci 18:2944-2953.
113. Flynn C, Brown CE, Galasso SL, McIntyre DC, Teskey GC, Dyck RH. 2007. Zincergic innervation of the forebrain distinguishes epilepsy-prone from epilepsy-resistant rat strains. Neuroscience 144:1409-1414. (Pubitemid 46123812)
114. Foresti ML, Arisi GM, Fernandes A, Tilelli CQ, Garcia-Cairasco N. 2008. Chelatable zinc modulates excitability and seizure duration in the amygdala rapid kindling model. Epilepsy Res 79: 166-172.
115. Forsythe ID, Westbrook GL, Mayer ML. 1988. Modulation of excitatory synaptic transmission by glycine and zinc in cultures of mouse hippocampal neurons. J Neurosci 8:3733-3741.
116. Fraker PJ. 2005. Roles for cell death in zinc deficiency. J Nutr 135:359-362. (Pubitemid 40365188)
117. Fraker PJ, Telford WG. 1997. A reappraisal of the role of zinc in life and death decisions of cells. Proc Soc Exp Biol Med 215:229-236. (Pubitemid 27274414)
118. Fraker PJ, King LE, Laakko T, Vollmer TL. 2000. The dynamic link between the integrity of the immune system and zinc status. J Nutr 130(5 Suppl):1399S-1406S. (Pubitemid 30244137)
119. Franco-Pons N, Casanovas-Aguilar C, Arroyo S, Rumià J, Pérez- Clausell J, Danscher G. 2000. Zinc-rich synaptic boutons in human temporal cortex biopsies. Neuroscience 98:429-435. (Pubitemid 30408163)
120. Franck JE, Pokorny J, Kunkel DD, Schwartzkroin PA. 1995. Physiologic and morphologic characteristics of granule cell circuitry in human epileptic hippocampus. Epilepsia 36:543-558.
121. Frederickson CJ. 1989. Neurobiology of zinc and zinc-containing neurons. Int Rev Neurobiol 31:145-238.
122. Frederickson CJ, Moncrieff DW. 1994. Zinc-containing neurons. Biol Signals 3:127-139.
123. Frederickson CJ, Bush AI. 2001. Synaptically released zinc: Physiological functions and pathological effects. Biometals 14:353-366.
124. Frederickson CJ, Hernandez MD, Goik SA, Morton JD, McGinty JF. 1988. Loss of zinc staining from hippocampal mossy fibers during kainic acid induced seizures: A histofluorescence study. Brain Res 446:383-386.
125. Frederickson RE, Frederickson CJ, Danscher G. 1990. In situ binding of bouton zinc reversibly disrupts performance on a spatial memory task. Behav Brain Res 38:25-33.
126. Frederickson CJ, Rampy BA, Reamy-Rampy S, Howell GA. 1992. Distribution of histochemically reactive zinc in the forebrain of the rat. J Chem Neuroanat 5:521-530.
127. Frederickson CJ, Suh SW, Silva D, Frederickson CJ, Thompson RB. 2000. Importance of zinc in the central nervous system: The zinc-containing neuron. J Nutr 130(5S Suppl):1471S-1483S. (Pubitemid 30244148)
128. Frederickson CJ, Koh JY, Bush AI. 2005a. The neurobiology of zinc in health and disease. Nat Rev Neurosci 6:449-462.
129. Frederickson CJ, Hershfinkel M, Giblin L. 2005b. The gluzinergic synapse: who's talking and who's listening? In: Stanton PK, Bramham C, Scharfman HE, editors. Synaptic plasticity and transsynaptic signaling. New York: Springer. p 123-137.
130. Frederickson CJ, Giblin LJ, Krezel A, McAdoo DJ, Mueller RN, Zeng Y, Balaji RV, Masalha R, Thompson RB, Fierke CA, Sarvey JM, de Valdenebro M, Prough DS, Zornow MH. 2006. Concentrations of extracellular free zinc (pZn)e in the central nervous system during simple anesthetization, ischemia and reperfusion. Exp Neurol 198:285-293.
131. Friedlich AL, Lee JY, van Groen T, Cherny RA, Volitakis I, Cole TB, Palmiter RD, Koh JY, Bush AI. 2004. Neuronal zinc exchange with the blood vessel wall promotes cerebral amyloid angiopathy in an animal model of Alzheimer's disease. J Neurosci 24:3453-3459. (Pubitemid 38451911)
132. Fukahori M, Itoh M. 1990. Effects of dietary zinc status on seizure susceptibility and hippocampal zinc content in the El (epilepsy) mouse. Brain Res 529:16-22. (Pubitemid 20326835)
133. Fukahori M, Itoh M, Oomagari K, Kawasaki H. 1988. Zinc content in discrete hippocampal and amygdaloid areas of the epilepsy (El) mouse and normal mice. Brain Res 455:381-384. (Pubitemid 18173679)
134. Fukamachi Y, Karasaki Y, Sugiura T, Itoh H, Abe T, Yamamura K, Higashi K. 1998. Zinc suppresses apoptosis of U937 cells induced by hydrogen peroxide through an increase of the Bcl-2/Bax ratio. Biochem Biophys Res Commun 246:364-369. (Pubitemid 28412604)
135. Gaeta A, Hider RC. 2005. The crucial role of metal ions in neurodegeneration: The basis for a promising therapeutic strategy. Br J Pharmacol 146:1041-1059. (Pubitemid 41786957)
136. Gaither LA, Eide DJ. 2000. Functional expression of the human hZIP2 zinc transporter. J Biol Chem 275:5560-5564. (Pubitemid 30115192)
137. Gaither LA, Eide DJ. 2001. Eukaryotic zinc transporters and their regulation. Biometals 14:251-270.
138. Galasso SL, Dyck RH. 2007. The role of zinc in cerebral ischemia. Mol Med 13:380-387.
139. Gardner JM, Powell CA, Baker-Henningham H, Walker SP, Cole TJ, Grantham-McGregor SM. 2005. Zinc supplementation and psychosocial stimulation: Effects on the development of undernourished Jamaican children. Am J Clin Nutr 82:399-405.
140. Garrett B, Slomianka L. 1992. Postnatal development of zinc-containing cells and neuropil in the visual cortex of the mouse. Anat Embryol (Berl) 186:487-496.
141. Gill CH, Peters JA, Lambert JJ. 1995. An electrophysiological investigation of the properties of a murine recombinant 5-HT3 receptor stably expressed in HEK 293 cells. Br J Pharmacol 114:1211-1221.
142. Giménez-Llort L, Blázquez G, Cañete T, Johansson B, Oddo S, Tobeña A, LaFerla FM, Fernández-Teruel A. 2007. Modeling behavioral and neuronal symptoms of Alzheimer's disease in mice: A role for intraneuronal amyloid. Neurosci Biobehav Rev 31:125-147. (Pubitemid 44895427)
143. Giralt M, Molinero A, Carrasco J, Hidalgo J. 2000. Effect of dietary zinc deficiency on brain metallothionein-I and -III mRNA levels during stress and inflammation. Neurochem Int 36:555-562. (Pubitemid 30101568)
144. Giralt M, Penkowa M, Lago N, Molinero A, Hidalgo J. 2002. Metallothionein- 1+2 protect the CNS after a focal brain injury. Exp Neurol 173:114-128. (Pubitemid 34081731)
145. Gombos Z, Spiller A, Cottrell GA, Racine RJ, McIntyre Burnham W. 1999. Mossy fiber sprouting induced by repeated electroconvulsive shock seizures. Brain Res 844:28-33. (Pubitemid 29490949)
146. Gong YH, Elliott JL. 2000. Metallothionein expression is altered in a transgenic murine model of familial amyotrophic lateral sclerosis. Exp Neurol 162:27-36.
147. Gong H, Takami Y, Amemiya T, Tozu M, Ohashi Y. 2004. Ocular surface in Zn-deficient rats. Ophthalmic Res 36:129-138.
148. Lewis DA, Gonzalez-Burgos G. 2006. Pathophysiologically based treatment interventions in schizophrenia. Nat Med 12:1016-1022. (Pubitemid 44353381)
149. Goodkin HP, Joshi S, Mtchedlishvili Z, Brar J, Kapur J. 2008. Subunit-specific trafficking of GABA(A) receptors during status epilepticus. J Neurosci 28:2527-2538. (Pubitemid 351348210)
150. Gorter JA, Petrozzino JJ, Aronica EM, Rosenbaum DM, Opitz T, Bennett MV, Connor JA, Zukin RS. 1997. Global ischemia induces downregulation of Glur2 mRNA and increases AMPA receptor-mediated Ca2+ influx in hippocampal CA1 neurons of gerbil. J Neurosci 17:6179-6188. (Pubitemid 27329893)
151. Gould TD, Manji HK. 2005. Glycogen synthase kinase-3: A putative molecular target for lithium mimetic drugs. Neuropsychopharmacology 30:1223-1237.
152. Grahn BH, Paterson PG, Gottschall-Pass KT, Zhang Z. 2001. Zinc and the eye. J Am Coll Nutr 20:106-118.
153. Hager LJ, Palmiter RD. 1981. Transcriptional regulation of mouse liver metallothionein-I gene by glucocorticoids. Nature 291:340-342. (Pubitemid 11083439)
154. Halas ES, Eberhardt MJ, Diers MA, Sandstead HH. 1983. Learning and memory impairment in adult rats due to severe zinc deficiency during lactation. Physiol Behav 30:371-381.
155. Halas ES, Hunt CD, Eberhardt MJ. 1986. Learning and memory disabilities in young adult rats from mildly zinc deficient dams. Physiol Behav 37:451-458.
156. Hamed SA, Abdellah MM. 2004. Trace elements and electrolytes homeostasis and their relation to antioxidant enzyme activity in brain hyperexcitability of epileptic patients. J Pharmacol Sci 96:349-359.
157. Hamer DH. 1986. Metallothionein. Annu Rev Biochem 55:913-951.
158. Harrison PJ. 2004. The hippocampus in schizophrenia: A review of the neuropathological evidence and its pathophysiological implications. Psychopharmacology (Berl) 174:151-162.
159. Harrison NL, Gibbons SJ. 1994. Zn2+: An endogenous modulator of ligand- and voltage-gated ion channels. Neuropharmacology 33:935-952. (Pubitemid 24290521)
160. Harrison PJ, Weinberger DR. 2005. Schizophrenia genes, gene expression, and neuropathology: On the matter of their convergence. Mol Psychiatry 10:40-68. (Pubitemid 40139588)
161. Hensley K, Aksenova M, Carney JM, Harris M, Butterfield DA. 1995. Amyloid beta-peptide spin trapping. I. Peptide enzyme toxicity is related to free radical spin trap reactivity. Neuroreport 6:489-492.
162. Hershkovitz E, Printzman L, Segev Y, Levy J, Phillip M. 1999. Zinc supplementation increases the level of serum insulin-like growth factor-I but does not promote growth in infants with nonorganic failure to thrive. Horm Res 52:200-204. (Pubitemid 30145269)
163. Hidalgo J, Aschner M, Zatta P, Vasák M. 2001. Roles of the metallothionein family of proteins in the central nervous system. Brain Res Bull 55:133-145. (Pubitemid 32722153)
164. Hirzel K, Müller U, Latal AT, Hülsmann S, Grudzinska J, Seeliger MW, Betz H, Laube B. 2006. Hyperekplexia phenotype of glycine receptor alpha1 subunit mutant mice identifies Zn(2+) as an essential endogenous modulator of glycinergic neurotransmission. Neuron 52:679-690. (Pubitemid 44750561)
165. Holcomb L, Gordon MN, McGowan E, Yu X, Benkovic S, Jantzen P, Wright K, Saad I, Mueller R, Morgan D, Sanders S, Zehr C, O'Campo K, Hardy J, Prada CM, Eckman C, Younkin S, Hsiao K, Duff K. 1998. Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes. Nat Med 4:97-100. (Pubitemid 28133087)
166. Howell GA, Welch MG, Frederickson CJ. 1984. Stimulation-induced uptake and release of zinc in hippocampal slices. Nature 308:736-738. (Pubitemid 14127671)
167. Howell GA, Perez-Clausell J, Frederickson CJ. 1991. Zinc containing projections to the bed nucleus of the stria terminalis. Brain Res 562:181-189.
168. Hsiao K, Chapman P, Nilsen S, Eckman C, Harigaya Y, Younkin S, Yang F, Cole G. 1996. Correlative memory deficits. Abeta elevation, and amyloid plaques in transgenic mice. Science 274:99-102.
169. Hsiao B, Dweck D, Luetje CW. 2001. Subunit-dependent modulation of neuronal nicotinic receptors by zinc. J Neurosci 21:1848-1856. (Pubitemid 32221368)
170. Huang L, Kirschke CP, Gitschier J. 2002. Functional characterization of a novel mammalian zinc transporter, ZnT6. J Biol Chem 277:26389-26395. (Pubitemid 34967132)
171. Huang L, Kirschke CP, Zhang Y, Yu YY. 2005. The ZIP7 gene (Slc39a7) encodes a zinc transporter involved in zinc homeostasis of the Golgi apparatus. J Biol Chem 280:15456-15463. (Pubitemid 40562904)
172. Huang X, Atwood CS, Moir RD, Hartshorn MA, Vonsattel JP, Tanzi RE, Bush AI. 1997. Zinc-induced Alzheimer's Abeta1-40 aggregation is mediated by conformational factors. J Biol Chem 272:26464-26470. (Pubitemid 27458865)
173. Huang X, Cuajungco MP, Atwood CS, Moir RD, Tanzi RE, Bush AI. 2000. Alzheimer's disease, beta-amyloid protein and zinc. J Nutr 130(5S Suppl):1488S-1492S. (Pubitemid 30244150)
174. Huang YZ, Pan E, Xiong ZQ, McNamara JO. 2008. Zinc-mediated transactivation of TrkB potentiates the hippocampal mossy fiber-CA3 pyramid synapse. Neuron 57:546-558. (Pubitemid 351273988)
175. Hubbard PC, Lummis SC. 2000. Zn(2+) enhancement of the recombinant 5-HT(3) receptor is modulated by divalent cations. Eur J Pharmacol 394:89-197.
176. Ibs KH, Rink L. 2003. Zinc-altered immune function. J Nutr 133(5 Suppl 1):1452S-1456S.
177. Ilouz R, Kaidanovich O, Gurwitz D, Eldar-Finkelman H. 2002. Inhibition of glycogen synthase kinase-3beta by bivalent zinc ions: Insight into the insulin-mimetic action of zinc. Biochem Biophys Res Commun 295:102-106. (Pubitemid 34743782)
178. Ishida N, Kasamo K, Nakamoto Y, Suzuki J. 1993. Epileptic seizure of El mouse initiates at the parietal cortex: Depth EEG observation in freely moving condition using buffer amplifier. Brain Res 608:52-57. (Pubitemid 23113850)
179. Itoh M, Ebadi M. 1982. The selective inhibition of hippocampal glutamic acid decarboxylase in zinc-induced epileptic seizures. Neurochem Res 7:1287-1298. (Pubitemid 13201876)
180. Jankowski-Hennig MA, Clegg MS, Daston GP, Rogers JM, Keen CL. 2000. Zinc-deficient rat embryos have increased caspase 3-like activity and apoptosis. Biochem Biophys Res Commun 271:250-256.
181. Jia Y, Jeng JM, Sensi SL, Weiss JH. 2002. Zn2+ currents are mediated by calcium-permeable AMPA/kainate channels in cultured murine hippocampal neurones. J Physiol 543(Pt 1):35-48. (Pubitemid 34947295)
182. Jiang L-J, Maret W, Vallee B. 1998. The glutathione redox couple modulates zinc transfer from metallothionein to zinc-depleted sorbitol dehydrogenase. Proc Natl Acad Sci USA 95:3483-3488. (Pubitemid 28173154)
183. Jo SM, Won MH, Cole TB, Jensen MS, Palmiter RD, Danscher G. 2000a. Zinc-enriched (ZEN) terminals in mouse olfactory bulb. Brain Res 865:227-236. (Pubitemid 30256001)
184. Jo SM, Danscher G, Daa Schrøder H, Won MH, Cole TB. 2000b. Zinc-enriched (ZEN) terminals in mouse spinal cord: Immunohistochemistry and autometallography. Brain Res 870:163-169. (Pubitemid 30408416)
185. Kägi HR. 1993. Evolution, structure and chemical activity of class I metallothioneins: An overview. In: Suzuki KT, Imura N, Kimura M, editors. Metallothionein III. Berlin: Birkhäuser Verlag. p 29-55.
186. Kambe T, Narita H, Yamaguchi-Iwai Y, Hirose J, Amano T, Sugiura N, Sasaki R, Mori K, Iwanaga T, Nagao M. 2002. Cloning and characterization of a novel mammalian zinc transporter, zinc transporter 5, abundantly expressed in pancreatic beta cells. J Biol Chem 277:19049-19055. (Pubitemid 34952469)
187. Kambe T, Yamaguchi-Iwai Y, Sasaki R, Nagao M. 2004. Overview of mammalian zinc transporters. Cell Mol Life Sci 61:49-68.
188. Karege F, Vaudan G, Schwald M, Perroud N, La Harpe R. 2005. Neurotrophin levels in postmortem brains of suicide victims and the effects of antemortem diagnosis and psychotropic drugs. Brain Res Mol Brain Res 136:29-37. (Pubitemid 40704606)
189. Karin M, Eddy RL, Henry WM, Haley LL, Byers MG, Shows TB. 1984. Human metallothionein genes are clustered on chromosome 16. Proc Natl Acad Sci USA 81:5494-5498. (Pubitemid 14000510)
190. Kay AR, Tóth K. 2008. Is zinc a neuromodulator? Sci Signal 1:re3.
191. Kim EY, Koh JY, Kim YH, Sohn S, Joe E, Gwag BJ. 1999a. Zn2+ entry produces oxidative neuronal necrosis in cortical cell cultures. Eur J Neurosci 11:327-334. (Pubitemid 29012335)
192. Kim YH, Kim EY, Gwag BJ, Sohn S, Koh JY. 1999b. Zinc-induced cortical neuronal death with features of apoptosis and necrosis: Mediation by free radicals. Neuroscience 89:175-182. (Pubitemid 29049037)
193. Kim TY, Hwang JJ, Yun SH, Jung MW, Koh JY. 2002. Augmentation by zinc of NMDA receptor-mediated synaptic responses in CA1 of rat hippocampal slices: Mediation by Src family tyrosine kinases. Synapse 46:49-56.
194. Kirschke CP, Huang L. 2003. ZnT7, a novel mammalian zinc transporter, accumulates zinc in the Golgi apparatus. J Biol Chem 278:4096-4102. (Pubitemid 36801145)
195. Kitamura Y, Iida Y, Abe J, Mifune M, Kasuya F, Ohta M, Igarashi K, Saito Y, Saji H. 2006. Release of vesicular Zn2+ in a rat transient middle cerebral artery occlusion model. Brain Res Bull 69:622-625. (Pubitemid 43728745)
196. Kitazawa M, Oddo S, Yamasaki TR, Green KN, LaFerla FM. 2005. Lipopolysaccharide-induced inflammation exacerbates tau pathology by a cyclin-dependent kinase 5-mediated pathway in a transgenic model of Alzheimer's disease. J Neurosci 25:8843-8853. (Pubitemid 41384452)
197. Klein C, Sunahara RK, Hudson TY, Heyduk T, Howlett AC. 2002. Zinc inhibition of cAMP signaling. J Biol Chem 277:11859-11865.
198. Klein C, Heyduk T, Sunahara RK. 2004. Zinc inhibition of adenylyl cyclase correlates with conformational changes in the enzyme. Cell Signal 16:1177-1185. (Pubitemid 38900520)
199. Kodirov SA, Takizawa S, Joseph J, Kandel ER, Shumyatsky GP, Bolshakov VY. 2006. Synaptically released zinc gates long-term potentiation in fear conditioing pathways. Proc Natl Acad Sci USA 103:15218-15223. (Pubitemid 44583191)
200. Koh JY, Suh SW, Gwag BJ, He YY, Hsu CY, Choi DW. 1996. The role of zinc in selective neuronal death after transient global cerebral ischemia. Science 272:1013-1016. (Pubitemid 26259319)
201. Köhr G, Mody I. 1994. Kindling increases N-methyl-D-aspartate potency at single N-methyl-D-aspartate channels in dentate gyrus granule cells. Neuroscience 62:975-981. (Pubitemid 24335594)
202. Kroczka B, Ziêba A, Dudek D, Pilc A, Nowak G. 2000. Zinc exhibits an antidepressant-like effect in the forced swimming test in mice. Pol J Pharmacol 52:403-406.
203. Kroczka B, Brañski P, Palucha A, Pilc A, Nowak G. 2001. Antidepressant- like properties of zinc in rodent forced swim test. Brain Res Bull 55:297-300. (Pubitemid 32722173)
204. Kunzmann A, Dedoussis G, Jajte J, Malavolta M, Mocchegiani E, Bürkle A. 2008. Effect of zinc on cellular poly(ADP-ribosylation capacity. Exp Gerontol 43:409-414.
205. Lamont SR, Paulls A, Stewart CA. 2001. Repeated electroconvulsive stimulation, but not antidepressant drugs, induces mossy fibre sprouting in the rat hippocampus. Brain Res 893:53-58. (Pubitemid 32171896)
206. Land PW, Akhtar ND. 1999. Experience-dependent alteration of synaptic zinc in rat somatosensory barrel cortex. Somatosens Mot Res 16:139-150. (Pubitemid 29352198)
207. Land PW, Shamalla-Hannah L. 2001. Transient expression of synaptic zinc during development of uncrossed retinogeniculate projections. J Comp Neurol 433:515-525. (Pubitemid 32336573)
208. Land PW, Shamalla-Hannah L. 2002. Experience-dependent plasticity of zinc-containing cortical circuits during a critical period of postnatal development. J Comp Neurol 447:43-56. (Pubitemid 34298844)
209. Larson AA, Kitto KF. 1997. Manipulations of zinc in the spinal cord, by intrathecal injection of zinc chloride, disodium-calcium-EDTA, or dipicolinic acid, alter nociceptive activity in mice. J Pharmacol Exp Ther 282:1319-1325.
210. Larson AA, Kitto KF. 1999. Chelation of zinc in the extracellular area of the spinal cord, using ethylenediaminetetraacetic acid disodium- calcium salt or dipicolinic acid, inhibits the antinociceptive effect of capsaicin in adult mice. J Pharmacol Exp Ther 288:759-765.
211. Lassalle JM, Bataille T, Halley H. 2000. Reversible inactivation of the hippocampal mossy fiber synapses in mice impairs spatial learning, but neither consolidation nor memory retrieval, in the Morris navigation task. Neurobiol Learn Mem 73:243-257. (Pubitemid 30250104)
212. Laube B. 2002. Potentiation of inhibitory glycinergic neurotransmission by Zn2+: A synergistic interplay between presynaptic P2X2 and postsynaptic glycine receptors. Eur J Neurosci 16:1025-1036. (Pubitemid 35463552)
213. Lavoie N, Peralta MR III, Chiasson M, Lafortune K, Pellegrini L, Seress L, To th K. 2007. Extracellular chelation of zinc does not affect hippocampal excitability and seizure-induced cell death in rats. J Physiol 578(Pt 1):275-289.
214. Lee JY, Mook-Jung I, Koh JY. 1999. Histochemically reactive zinc in plaques of the Swedish mutant beta-amyloid precursor protein transgenic mice. J Neurosci 19:RC10.
215. Lee JY, Cole TB, Palmiter RD, Suh SW, Koh JY. 2002a. Contribution by synaptic zinc to the gender-disparate plaque formation in human Swedish mutant APP transgenic mice. Proc Natl Acad Sci USA 99:7705-7710.
216. Lee JM, Zipfel GJ, Park KH, He YY, Hsu CY, Choi DW. 2002b. Zinc translocation accelerates infarction after mild transient focal ischemia. Neuroscience 115:871-878.
217. Lee JY, Friedman JE, Angel I, Kozak A, Koh JY. 2004. The lipophilic metal chelator DP-109 reduces amyloid pathology in brains of human beta-amyloid precursor protein transgenic mice. Neurobiol Aging 25:1315-1321. (Pubitemid 39299169)
218. Lengyel I, Fieuw-Makaroff S, Hall AL, Sim AT, Rostas JA, Dunkley PR. 2000. Modulation of the phosphorylation and activity of calcium/calmodulin- dependent protein kinase II by zinc. J Neurochem 75:594-605. (Pubitemid 30485440)
219. Lewis DA, Hashimoto T. 2007. Deciphering the disease process of schizophrenia: The contribution of cortical gaba neurons. Int Rev Neurobiol 78:109-131.
220. Li Y, Hough CJ, Suh SW, Sarvey JM, Frederickson CJ. 2001. Rapid translocation of Zn(2+) from presynaptic terminals into postsynaptic hippocampal neurons after physiological stimulation. J Neurophysiol 86:2597-2604. (Pubitemid 34000617)
221. Lin DD, Cohen AS, Coulter DA. 2001. Zinc-induced augmentation of excitatory synaptic currents and glutamate receptor responses in hippocampal CA3 neurons. J Neurophysiol 85:1185-1196.
222. Link TA, von Jagow G. 1995. Zinc ions inhibit the QP center of bovine heart mitochondrial bc1 complex by blocking a protonatable group. J Biol Chem 270:25001-25006.
223. Linkous DH, Flinn JM, Koh JY, Lanzirotti A, Bertsch PM, Jones BF, Giblin LJ, Frederickson CJ. 2008. Evidence that the ZNT3 protein controls the total amount of element al zinc in synaptic vesicles. J Histochem Cytochem 56:3-6. (Pubitemid 350276496)
224. Liochev SI, Chen LL, Hallewell RA, Fridovich I. 1997. Superoxide-dependent peroxidase activity of H48Q: A superoxide dismutase variant associated with familial amyotrophic lateral sclerosis. Arch Biochem Biophys 346:263-268. (Pubitemid 27439044)
225. Lipska BK. 2004. Using animal models to test a neurodevelopmental hypothesis of schizophrenia. J Psychiatry Neurosci 29:282-286.
226. Lipska BK, Weinberger DR. 2000. To model a psychiatric disorder in animals: Schizophrenia as a reality test. Neuropsychopharmacology 23:223-239.
227. Liuzzi JP, Cousins RJ. 2004. Mammalian zinc transporters. Annu Rev Nutr 24:151-172.
228. Long Y, Hardwick AL, Frederickson CJ. 1995. Zinc-containing innervation of the subicular region in the rat. Neurochem Int 27:95-103.
229. Lopantsev V, Wenzel HJ, Cole TB, Palmiter RD, Schwartzkroin PA. 2001. Lack of vesicular zinc in mossy fibers does not affect synaptic excitability of CA3 pyramidal cells in zinc transporter 3 knockout mice. Neuroscience 116:237-248. (Pubitemid 36110449)
230. Lovell MA, Robertson JD, Teesdale WJ, Campbell JL, Markesbery WR. 1998. Copper, iron and zinc in Alzheimer's disease senile plaques. J Neurol Sci 158:47-52.
231. Lu YM, Yin HZ, Chiang J, Weiss JH. 1996. Ca(2+)-permeable AMPA/kainate and NMDA channels: High rate of Ca2+ influx underlies potent induction of injury. J Neurosci 16:5457-5465. (Pubitemid 26277874)
232. Lu YM, Taverna FA, Tu R, Ackerley CA, Wang YT, Roder J. 2000. Endogenous Zn(2+) is required for the induction of long-term potentiation at rat hippocampal mossy fiber-CA3 synapses. Synapse 38:187-197.
233. Lyons TJ, Nersissian A, Huang H, Yeom H, Nishida CR, Graden JA, Gralla EB, Valentine JS. 2000. The metal binding properties of the zinc site of yeast copper-zinc superoxide dismutase: Implications for amyotrophic lateral sclerosis. J Biol Inorg Chem 5:189-203. (Pubitemid 30249402)
234. Macdonald RS. 2000. The role of zinc in growth and cell proliferation. J Nutr 130(5S Suppl):1500S-1508S.
235. Macdonald RL, Kapur J. 1999. Acute cellular alterations in the hippocampus after status epilepticus. Epilepsia 40(Suppl 1):S9-S20. (Pubitemid 29367108)
236. Macdonald RL, Olsen RW. 1994. GABAA receptor channels. Annu Rev Neurosci 17:569-602.
237. Mackay-Sim A, Dreosti IE. 1989. Olfactory function in zinc-deficient adult mice. Exp Brain Res 76:207-212. (Pubitemid 19167233)
238. Mackenzie GG, Oteiza PI. 2007. Zinc and the cytoskeleton in the neuronal modulation of transcription factor NFAT. J Cell Physiol 210:246-256. (Pubitemid 44911041)
239. Mackenzie GG, Zago MP, Keen CL, Oteiza PI. 2002. Low intracellular zinc impairs the translocation of activated NF-kappa B to the nuclei in human neuroblastoma IMR-32 cells. J Biol Chem 277:34610-34617.
240. Mackenzie GG, Keen CL, Oteiza PI. 2006. Microtubules are required for NF-kappaB nuclear translocation in neuroblastoma IMR-32 cells: Modulation by zinc. J Neurochem 99:402-415.
241. Maes M, D'Haese PC, Scharpe S, D'Hondt PD, Cosyns P, De Broe ME. 1994. Hypozincemia in depression. J Affect Disord 31:135-140.
242. Maes M, Vandoolaeghe E, Neels H, Demedts P, Wauters A, Meltzer HY, Altamura C, Desnyder R. 1997. Lower serum zinc in major depression is a selective marker of resistance and of the immune/inflammatory response in that illness. Biol Psychiatry 42:349-358. (Pubitemid 27380969)
243. Malaiyandi LM, Honick AS, Rintoul GL, Wang QJ, Reynolds IJ. 2005. Zn2+ inhibits mitochondrial movement in neurons by phosphatidylinositol 3-kinase activation. J Neurosci 25:9507-9514.
244. Mandava P, Howell GA, Frederickson CJ. 1993. Zinc-containing neuronal innervation of the septal nuclei. Brain Res 608:115-122. (Pubitemid 23113858)
245. Marcellini F, Giuli C, Papa R, Gagliardi C, Dedoussis G, Herbein G, Fulop T, Monti D, Rink L, Jajte J, Mocchegiani E. 2006. Zinc status, psychological and nutritional assessment in old people recruited in five European countries: Zincage study. Biogerontology 7:339-345.
246. Maret W. 1995. Metallothionein/disulfide interactions, oxidative stress, and the mobilization of cellular zinc. Neurochem Int 27:111-117.
247. Maret W. 2000. The function of zinc metallothionein: A link between cellular zinc and redox state. J Nutr 130(5S Suppl):1455S-1458S. (Pubitemid 30244145)
248. Maret W, Vallee BL. 1998. Thiolate ligands in metallothionein confer redox activity on zinc clusters. Proc Natl Acad Sci USA 95:3478-3482. (Pubitemid 28173153)
249. Markesbery WR. 1997. Oxidative stress hypothesis in Alzheimer's disease. Free Radic Biol Med 23:134-147. (Pubitemid 27217017)
250. Martin SJ, Grimwood PD, Morris RG. 2000. Synaptic plasticity and memory: An evaluation of the hypothesis. Annu Rev Neurosci 23:649-711. (Pubitemid 30350057)
251. Maske H. 1955. Über den topochemischen Nachweis von Zink im Ammonshorn verschiedener Säugetiere. Naturwissenschaften 42:424.
252. Masters BA, Quaife CJ, Erickson JC, Kelly EJ, Froelick GJ, Zambrowicz BP, Brinster RL, Palmiter RD. 1994. Metallothionein III is expressed in neurons that sequester zinc in synaptic vesicles. J Neurosci 14:5844-5857.
253. Mattson MP, Meffert MK. 2006. Roles for NF-kappaB in nerve cell survival, plasticity, and disease. Cell Death Differ 13:852-860.
254. Mayberg HS. 2007. Defining the neural circuitry of depression: Toward a new nosology with therapeutic implications. Biol Psychiatry 61:729-730.
255. Mayer ML, Vyklicky L Jr. 1989. The action of zinc on synaptic transmission and neuronal excitability in cultures of mouse hippocampus. J Physiol 415:351-365.
256. McBain CJ, Dingledine R. 1993. Heterogeneity of synaptic glutamate receptors on CA3 stratum radiatum interneurones of rat hippocampus. J Physiol 462:373-392. (Pubitemid 23094486)
257. McClain CJ, Su LC, Gilbert H, Cameron D. 1983. Zinc-deficiency-induced retinal dysfunction in Crohn's disease. Dig Dis Sci 28:85-87. (Pubitemid 13223407)
258. McLaughlin B, Pal S, Tran MP, Parsons AA, Barone FC, Erhardt JA, Aizenman E. 2001. p38 activation is required upstream of potassium current enhancement and caspase cleavage in thiol oxidant-induced neuronal apoptosis. J Neurosci 21:3303-3311. (Pubitemid 32422795)
259. McLoughlin IJ, Hodge SJ. 1990. Zinc in depressive disorder. Acta Psychiatr Scand 82:451-453.
260. McMahon RJ, Cousins RJ. 1998. Regulation of the zinc transporter ZnT-1 by dietary zinc. Proc Natl Acad Sci USA 95:4841-4846.
261. McNall AD, Etherton TD, Fosmire GJ. 1995. The impaired growth induced by zinc deficiency in rats is associated with decreased expression of the hepatic insulin-like growth factor I and growth hormone receptor genes. J Nutr 125:874-879.
262. Meloni G, Faller P, Vasák M. 2007. Redox silencing of copper in metal-linked neurodegenerative disorders: Reaction of Zn7metallothionein- 3 with Cu2+ ions. J Biol Chem 282:16068-16078. (Pubitemid 47100352)
263. Meloni G, Sonois V, Delaine T, Guilloreau L, Gillet A, Teissié J, Faller P, Vasák M. 2008. Metal swap between Zn7-metallothionein- 3 and amyloid-beta-Cu protects against amyloid-beta toxicity. Nat Chem Biol 4:366-372. (Pubitemid 351693994)
264. Midorikawa R, Takei Y, Hirokawa N. 2006. KIF4 motor regulates activity-dependent neuronal survival by suppressing PARP-1 enzymatic activity. Cell 125:371-383.
265. Miller PS, Da Silva HM, Smart TG. 2005. Molecular basis for zinc potentiation at strychnine-sensitive glycine receptors. J Biol Chem 280:37877-37884.
266. Mills DA, Schmidt B, Hiser C, Westley E, Ferguson-Miller S. 2002. Membrane potential-controlled inhibition of cytochrome c oxidase by zinc. J Biol Chem 277:14894-14901. (Pubitemid 34952563)
267. Min YK, Lee JE, Chung KC. 2007. Zinc induces cell death in immortalized embryonic hippocampal cells via activation of Akt-GSK-3beta signaling. Exp Cell Res 313:312-321.
268. Mitchell CL, Barnes MI. 1993. Proconvulsant action of diethyldithiocarbamate in stimulation of the perforant path. Neurotoxicol Teratol 15:165-171. (Pubitemid 23153879)
269. Miyawaki T, Mashiko T, Ofengeim D, Flannery RJ, Noh KM, Fujisawa S, Bonanni L, Bennett MV, Zukin RS, Jonas EA. 2008. Ischemic preconditioning blocks BAD translocation. Bcl-xL cleavage, and large channel activity in mitochondria of postischemic hippocampal neurons. Proc Natl Acad Sci USA 105:4892-4897.
270. Mocchegiani E, Muzzioli M, Giacconi R. 2000. Zinc and immunoresistance to infection in aging: New biological tools. Trends Pharmacol Sci 21:205-208. (Pubitemid 30331087)
271. Mocchegiani E, Giacconi R, Cipriano C, Muzzioli M, Fattoretti P, Bertoni-Freddari C, Isani G, Zambenedetti P, Zatta P. 2001. Zinc-bound metallothioneins as potential biological markers of ageing. Brain Res Bull 55:147-153. (Pubitemid 32722154)
272. Mocchegiani E, Bertoni-Freddari C, Marcellini F, Malavolta M. 2005. Brain, aging and neurodegeneration: Role of zinc ion availability. Prog Neurobiol 75:367-390. (Pubitemid 40827125)
273. Moffatt P, Denizeau F. 1997. Metallothionein in physiological and physiopathological processes. Drug Metab Rev 29:261-307.
274. Monnerie H, Le Roux PD. 2007. Reduced dendrite growth and altered glutamic acid decarboxylase (GAD) 65- and 67-kDa isoform protein expression from mouse cortical GABAergic neurons following excitotoxic injury in vitro. Exp Neurol 205:367-382. (Pubitemid 46755759)
275. Morton JD, Howell GA, Frederickson CJ. 1990. Effects of subcutaneous injections of zinc chloride on seizures induced by noise and by kainic acid. Epilepsia 31:139-144.
276. Muller D, Toni N, Buchs PA. 2000. Spine changes associated with long-term potentiation. Hippocampus 10:596-604. (Pubitemid 30833803)
277. Muller D, Nikonenko I, Jourdain P, Alberi S. 2002. LTP, memory and structural plasticity. Curr Mol Med 2:605-611.
278. Mulligan VK, Kerman A, Ho S, Chakrabartty A. 2008. Denaturational stress induces formation of zinc-deficient monomers of Cu,Zn superoxide dismutase: Implications for pathogenesis in amyotrophic lateral sclerosis. J Mol Biol 383:424-436.
279. Multhaup G, Bush AI, Pollwein P, Masters CL. 1994. Interaction between the zinc (II) and the heparin binding site of the Alzheimer's disease beta A4 amyloid precursor protein (APP). FEBS Lett 355:151-154. (Pubitemid 24355107)
280. Multhaup G, Ruppert T, Schlicksupp A, Hesse L, Bill E, Pipkorn R, Masters CL, Beyreuther K. 1998. Copper-binding amyloid precursor protein undergoes a site-specific fragmentation in the reduction of hydrogen peroxide. Biochemistry 37:7224-7230. (Pubitemid 28235203)
281. Nagano S, Satoh M, Sumi H, Fujimura H, Tohyama C, Yanagihara T, Sakoda S. 2001. Reduction of metallothioneins promotes the disease expression of familial amyotrophic lateral sclerosis mice in a dose-dependent manner. Eur J Neurosci 13:1363-1370. (Pubitemid 32328490)
282. Nakashima AS, Dyck RH. 2008. Enhanced plasticity in zincergic, cortical circuits after exposure to enriched environments. J Neurosci 28:13995-13999.
283. Nakashima AS, Dyck RH. 2009. Zinc and cortical plasticity. Brain Res Rev 59:347-373.
284. Nakashima AS, Oddo S, Laferla FM, Dyck RH. 2008. Experience-dependent regulation of vesicular zinc in male and female 3xTg-AD mice. Neurobiol Aging [Epub ahead of print].
285. Nishimura T, Schwarzer C, Gasser E, Kato N, Vezzani A, Sperk G. 2005. Altered expression of GABA(A) and GABA(B) receptor subunit mRNAs in the hippocampus after kindling and electrically induced status epilepticus. Neuroscience 134:691-704. (Pubitemid 41111795)
286. Noh KM, Yokota H, Mashiko T, Castillo PE, Zukin RS, Bennett MV. 2005. Blockade of calcium-permeable AMPA receptors protects hippocampal neurons against global ischemia-induced death. Proc Natl Acad Sci USA 102:12230-12235. (Pubitemid 41291157)
287. Nowak G, Schlegel-Zawadzka M. 1999. Alterations in serum and brain trace element levels after antidepressant treatment. I. Zinc. Biol Trace Elem Res 67:85-92. (Pubitemid 29094235)
288. Nowak G, Szewczyk B, Wieroñska JM, Brañski P, Palucha A, Pilc A, Sadlik K, Piekoszewski W. 2003. Antidepressant-like effects of acute and chronic treatment with zinc in forced swim test and olfactory bulbectomy model in rats. Brain Res Bull 61:159-164. (Pubitemid 36794273)
289. Nowak G, Legutko B, Szewczyk B, Papp M, Sanak M, Pilc A. 2004. Zinc treatment induces cortical brain-derived neurotrophic factor gene expression. Eur J Pharmacol 492:57-59. (Pubitemid 38624422)
290. Nowak G, Szewczyk B, Pilc A. 2005. Zinc and depression. An update. Pharmacol Rep 57:713-718.
291. O'Brien WT, Harper AD, Jové F, Woodgett JR, Maretto S, Piccolo S, Klein PS. 2004. Glycogen synthase kinase-3beta haploinsufficiency mimics the behavioral and molecular effects of lithium. J Neurosci 24:6791-6798. (Pubitemid 38993901)
292. Oddo S, Caccamo A, Kitazawa M, Tseng BP, LaFerla FM. 2003a. Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer's disease. Neurobiol Aging 24:1063-1070. (Pubitemid 37487883)
293. Oddo S, Caccamo A, Shepherd JD, Murphy MP, Golde TE, Kayed R, Metherate R, Mattson MP, Akbari Y, LaFerla FM. 2003b. Triple-transgenic model of Alzheimer's disease with plaques and tangles: Intracellular Abeta and synaptic dysfunction. Neuron 39:409-421. (Pubitemid 36937044)
294. Oddo S, Caccamo A, Green KN, Liang K, Tran L, Chen Y, Leslie FM, LaFerla FM. 2005. Chronic nicotine administration exacerbates tau pathology in a transgenic model of Alzheimer's disease. Proc Natl Acad Sci USA 102:3046-3051. (Pubitemid 40299913)
295. Okazaki MM, Evenson DA, Nadler JV. 1995. Hippocampal mossy fiber sprouting and synapse formation after status epilepticus in rats: Visualization after retrograde transport of biocytin. J Comp Neurol 352:515-534.
296. Opitz T, Grooms SY, Bennett MV, Zukin RS. 2000. Remodeling of alpha-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid receptor subunit composition in hippocampal neurons after global ischemia. Proc Natl Acad Sci USA 97:13360-13365.
297. Palmiter RD, Findley SD. 1995. Cloning and functional characterization of a mammalian zinc transporter that confers resistance to zinc. EMBO J 14:639-649.
298. Palmiter RD, Huang L. 2004. Efflux and compartmentalization of zinc by members of the SLC30 family of solute carriers. Pflugers Arch 447:744-751. (Pubitemid 38241460)
299. Palmiter RD, Cole TB, Quaife CJ, Findley SD. 1996a. ZnT-3, a putative transporter of zinc into synaptic vesicles. Proc Natl Acad Sci USA 93:14934-14939.
300. Palmiter RD, Cole TB, Findley SD. 1996b. ZnT-2, a mammalian protein that confers resistance to zinc by facilitating vesicular sequestration. EMBO J 15:1784-1791.
301. Palmiter RD, Findley SD, Whitmore TE, Durnam DM. 1992. MT-III, a brain-specific member of the metallothionein gene family. Proc Natl Acad Sci USA 89:6333-6337.
302. Panayi AE, Spyrou NM, Iversen BS, White MA, Part P. 2002. Determination of cadmium and zinc in Alzheimer's brain tissue using inductively coupled plasma mass spectrometry. J Neurol Sci 195:1-10. (Pubitemid 34175093)
303. Pei Y, Zhao D, Huang J, Cao L. 1983. Zinc-induced seizures: A new experimental model of epilepsy. Epilepsia 24:169-176.
304. Pellegrini-Giampietro DE, Gorter JA, Bennett MV, Zukin RS. 1997. The GluR2 (GluR-B) hypothesis: Ca(2+)-permeable AMPA receptors in neurological disorders. Trends Neurosci 20:464-470.
305. Penkowa M, Nielsen H, Hidalgo J, Bernth N, Moos T. 1999. Distribution of metallothionein I + II and vesicular zinc in the developing central nervous system: Correlative study in the rat. J Comp Neurol 412:303-318. (Pubitemid 29395367)
306. Penkowa M, Giralt M, Camats J, Hidalgo J. 2002. Metallothionein 1+2 protect the CNS during neuroglial degeneration induced by 6-aminonicotinamide. J Comp Neurol 444:174-189. (Pubitemid 34111989)
307. Pérez-Clausell J, Danscher G. 1985. Intravesicular localization of zinc in rat telencephalic boutons. A histochemical study. Brain Res 337:91-98.
308. Pérez-Clausell J, Danscher G. 1986. Release of zinc sulphide accumulations into synaptic clefts after in vivo injection of sodium sulphide. Brain Res 362:358-361. (Pubitemid 16170176)
309. Pérez-Clausell J, Frederickson CJ, Danscher G. 1989. Amygdaloid efferents through the stria terminalis in the rat give origin to zinc-containing boutons. J Comp Neurol 290:201-212. (Pubitemid 20006319)
310. Perry DK, Smyth MJ, Stennicke HR, Salvesen GS, Duriez P, Poirier GG, Hannun YA. 1997. Zinc is a potent inhibitor of the apoptotic protease, caspase-3. A novel target for zinc in the inhibition of apoptosis. J Biol Chem 272:18530-18533. (Pubitemid 27318188)
311. Porter BE, Zhang G, Celix J, Hsu FC, Raol YH, Telfeian A, Gallagher PR, Coulter DA, Brooks-Kayal AR. 2005. Heterogeneous GABAA receptor subunit expression in pediatric epilepsy patients. Neurobiol Dis 18:484-491. (Pubitemid 40340142)
312. Powell SR. 2000. The antioxidant properties of zinc. J Nutr 130(5S Suppl):1447S-154S.
313. Prasad AS. 1995. Zinc: An overview. Nutrition 11(1 Suppl):93-99.
314. Prasad AS. 2003. Zinc deficiency. BMJ 326:409-410.
315. Prasad AS. 2008. Zinc in human health: Effect of zinc on immune cells. Mol Med 14:353-357. (Pubitemid 351785709)
316. Prasad AS, Bao B, Beck FW, Kucuk O, Sarkar FH. 2004. Antioxidant effect of zinc in humans. Free Radic Biol Med 37:1182-1190.
317. Pulsinelli WA, Brierley JB, Plum F. 1982. Temporal profile of neuronal damage in a model of transient forebrain ischemia. Ann Neurol 11:491-498.
318. Puttaparthi K, Gitomer WL, Krishnan U, Son M, Rajendran B, Elliott JL. 2002. Disease progression in a transgenic model of familial amyotrophic lateral sclerosis is dependent on both neuronal and non-neuronal zinc binding proteins. J Neurosci 22:8790-8796. (Pubitemid 35379048)
319. Qian J, Noebels JL. 2005 Visualization of transmitter release with zinc fluorescence detection at the mouse hippocampal mossy fibre synapse. J Physiol 566:747-758. (Pubitemid 41122658)
320. Quaife CJ, Findley SD, Erickson JC, Froelick GJ, Kelly EJ, Zambrowicz BP, Palmiter RD. 1994. Induction of a new metallothionein isoform (MT-IV) occurs during differentiation of stratified squamous epithelia. Biochemistry 33:7250-7259.
321. Quinta-Ferreira ME, Matias CM. 2004. Hippocampal mossy fiber calcium transients are maintained during long-term potentiation and are inhibited by endogenous zinc. Brain Res 1004:52-60.
322. Quiroz JA, Gould TD, Manji HK. 2004. Molecular effects of lithium. Mol Interv 4:259-272.
323. Rassendren FA, Lory P, Pin JP, Nargeot J. 1990. Zinc has opposite effects on NMDA and non-NMDA receptors expressed in Xenopus oocytes. Neuron 4:733-740. (Pubitemid 20185088)
324. Redenti S, Chappell RL. 2005. Neuroimaging of zinc released by depolarization of rat retinal cells. Vision Res 45:3520-3525. (Pubitemid 41737380)
325. Redenti S, Ripps H, Chappell RL. 2007. Zinc release at the synaptic terminals of rod photoreceptors. Exp Eye Res 85:580-584. (Pubitemid 47542267)
326. Remy S, Spruston N. 2007. Dendritic spikes induce single-burst long-term potentiation. Proc Natl Acad Sci USA 104:17192-17197. (Pubitemid 350211013)
327. Rink L, Gabriel P. 2000. Zinc and the immune system. Proc Nutr Soc 59:541-552.
328. Rink L, Kirchner H. 2000. Zinc-altered immune function and cytokine production. J Nutr 130(5S Suppl):1407S-1411S. (Pubitemid 30244138)
329. Robbins AH, Stout CD. 1991. X-ray structure of metallothionein. Methods Enzymol 205:485-502.
330. Roberts BR, Tainer JA, Getzoff ED, Malencik DA, Anderson SR, Bomben VC, Meyers KR, Karplus PA, Beckman JS. 2007. Structural characterization of zinc-deficient human superoxide dismutase and implications for ALS. J Mol Biol 373:877-890.
331. Roe JA, Wiedau-Pazos M, Moy VN, Goto JJ, Gralla EB, Valentine JS. 2002. In vivo peroxidative activity of FALS-mutant human CuZnSODs expressed in yeast. Free Radic Biol Med 32: 169-174.
332. Rosa AO, Lin J, Calixto JB, Santos AR, Rodrigues AL. 2003. Involvement of NMDA receptors and L-arginine-nitric oxide pathway in the antidepressant-like effects of zinc in mice. Behav Brain Res 144:87-93. (Pubitemid 37011169)
333. Rosati AM, Traversa U. 1999. Mechanisms of inhibitory effects of zinc and cadmium ions on agonist binding to adenosine A1 receptors in rat brain. Biochem Pharmacol 58:623-632. (Pubitemid 29296882)
334. Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, Hentati A, Donaldson D, Goto J, O'Regan JP, Deng HX, Rahmani Z, Krizus A, McKenna-Yasek D, Cayabyab A, Gaston SM, Berger R, Tanzi RE, Halperin JT, Herzfeldt B, Van den Bergh R, Hung W-Y, Bird T, Deng G, Mulder DW, Smyth C, Laing NG, Soriano E, Pericak- Vance MA, Haines J, Rouleau GA, Gusella JS, Horvitz HR, Brown Jr RH. 1993. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362:59-62. (Pubitemid 23087289)
335. Ross GM, Shamovsky IL, Lawrance G, Solc M, Dostaler SM, Jimmo SL, Weaver DF, Riopelle RJ. 1997. Zinc alters conformation and inhibits biological activities of nerve growth factor and related neurotrophins. Nat Med 3:872-878. (Pubitemid 27353447)
336. Rubio ME, Juiz JM. 1998. Chemical anatomy of excitatory endings in the dorsal cochlear nucleus of the rat: Differential synaptic distribution of aspartate aminotransferase, glutamate, and vesicular zinc. J Comp Neurol 399:341-358.
337. Rulon LL, Robertson JD, Lovell MA, Deibel MA, Ehmann WD, Markesber WR. 2000. Serum zinc levels and Alzheimer's disease. Biol Trace Elem Res 75:79-85. (Pubitemid 30470256)
338. Saito T, Takahashi K, Nakagawa N, Hosokawa T, Kurasaki M, Yamanoshita O, Yamamoto Y, Sasaki H, Nagashima K, Fujita H. 2000. Deficiencies of hippocampal Zn and ZnT3 accelerate brain aging of Rat. Biochem Biophys Res Commun 279:505-511. (Pubitemid 32016745)
339. Samudralwar DL, Diprete CC, Ni BF, Ehmann WD, Markesbery WR. 1995. Elemental imbalances in the olfactory pathway in Alzheimer's disease. J Neurol Sci 130:139-145.
340. Sandstead HH. 2003. Zinc is essential for brain development and function. J Trace Elem Exp Med 16:165-173. (Pubitemid 37392612)
341. Sandstead HH, Frederickson CJ, Penland JG. 2000. History of zinc as related to brain function. J Nutr 130(2S Suppl):496S-502S.
342. 2 dopamine receptors. J Neurochem 68:1990-1997.
343. 2-like dopamine receptors through distinct molecular mechanisms. J Pharmacol Exp Ther 289:956-964.
344. Sekler I, Moran A, Hershfinkel M, Dori A, Margulis A, Birenzweig N, Nitzan Y, Silverman WF. 2002. Distribution of the zinc transporter ZnT-1 in comparison with chelatable zinc in the mouse brain. J Comp Neurol 447:201-209. (Pubitemid 34461449)
345. Sekler I, Sensi SL, Hershfinkel M, Silverman WF. 2007. Mechanism and regulation of cellular zinc transport. Mol Med 13:337-343. (Pubitemid 47378133)
346. Sensi SL, Jeng JM. 2004. Rethinking the excitotoxic ionic milieu: The emerging role of Zn(2+) in ischemic neuronal injury. Curr Mol Med 4:87-111.
347. Sensi SL, Yin HZ, Carriedo SG, Rao SS, Weiss JH. 1999. Preferential Zn2+ influx through Ca2+-permeable AMPA/kainate channels triggers prolonged mitochondrial superoxide production. Proc Natl Acad Sci USA 96:2414-2419.
348. Sensi SL, Yin HZ, Weiss JH. 2000. AMPA/kainate receptor-triggered Zn2+ entry into cortical neurons induces mitochondrial Zn2+ uptake and persistent mitochondrial dysfunction. Eur J Neurosci 12:3813-3818.
349. Sensi SL, Ton-That D, Weiss JH. 2002. Mitochondrial sequestration and Ca(2+)-dependent release of cytosolic Zn(2+) loads in cortical neurons. Neurobiol Dis 10:100-108.
350. Sensi SL, Ton-That D, Sullivan PG, Jonas EA, Gee KR, Kaczmarek LK, Weiss JH. 2003. Modulation of mitochondrial function by endogenous Zn2+ pools. Proc Natl Acad Sci USA 100:6157-6162. (Pubitemid 36576947)
351. Sensi SL, Rockabrand RL, Sekler I. 2007. Zinc homeostasis and brain injury. In: Malva J, Rego AC, Oliveira C, Cunha R, editors. Interaction between neurons and glia in aging and disease. New York: Springer. p 221-244.
352. Sensi SL, Rapposelli IG, Frazzini V, Mascetra N. 2008. Altered oxidant- mediated intraneuronal zinc mobilization in a triple transgenic mouse model of Alzheimer's disease. Exp Gerontol 43:488-492.
353. Seve M, Chimienti F, Devergnas S, Favier A. 2004. In silico identification and expression of SLC30 family genes: An expressed sequence tag data mining strategy for the characterization of zinc transporters' tissue expression. BMC Genomics 5:32.
354. Sheline CT, Behrens MM, Choi DW. 2000. Zinc-induced cortical neuronal death: Contribution of energy failure attributable to loss of NAD(+) and inhibition of glycolysis. J Neurosci 20:3139-3146.
355. Shigihara S, Ikui A, Shigihara J, Tomita H, Okano M. 1987. Electron microscopy of the olfactory epithelium in zinc deficient rats. Ann N Y Acad Sci 510:606-609. (Pubitemid 18099260)
356. Shirayama Y, Chen AC, Nakagawa S, Russell DS, Duman RS. 2002. Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression. J Neurosci 22:3251-3261. (Pubitemid 35379212)
357. Sillevis Smitt PA, Blaauwgeers HG, Troost D, de Jong JM. 1992. Metallothionein immunoreactivity is increased in the spinal cord of patients with amyotrophic lateral sclerosis. Neurosci Lett 144:107-110.
358. Sillevis Smitt PA, Mulder TP, Verspaget HW, Blaauwgeers HG, Troost D, de Jong JM. 1994. Metallothionein in amyotrophic lateral sclerosis. Bio Signals 3:193-197.
359. Sindreu CB, Varoqui H, Erickson JD, Pérez-Clausell J. 2003. Boutons containing vesicular zinc define a subpopulation of synapses with low AMPAR content in rat hippocampus. Cereb Cortex 13:823-829. (Pubitemid 36917961)
360. Singh RJ, Karoui H, Gunther MR, Beckman JS, Mason RP, Kalyanaraman B. 1998. Reexamination of the mechanism of hydroxyl radical adducts formed from the reaction between familial amyotrophic lateral sclerosis-associated Cu, Zn superoxide dismutase mutants and H2O2. Proc Natl Acad Sci USA 95:6675-6680. (Pubitemid 28278039)
361. Siuciak JA, Lewis DR, Wiegand SJ, Lindsay RM. 1997. Antidepressant- like effect of brain-derived neurotrophic factor (BDNF). Pharmacol Biochem Behav 56:131-137. (Pubitemid 27016116)
362. Skolnick P, Legutko B, Li X, Bymaster FP. 2001. Current perspectives on the development of non-biogenic amine-based antidepressants. Pharmacol Res 43:411-423. (Pubitemid 32578856)
363. Slomianka L. 1992. Neurons of origin of zinc-containing pathways and the distribution of zinc-containing boutons in the hippocampal region of the rat. Neuroscience 48:325-352.
364. Slomianka L, Danscher G, Frederickson CJ. 1990. Labeling of the neurons of origin of zinc-containing pathways by intraperitoneal injections of sodium selenite. Neuroscience 38:843-854. (Pubitemid 20383219)
365. Sloviter RS. 1985. A selective loss of hippocampal mossy fiber Timm stain accompanies granule cell seizure activity induced by perforant path stimulation. Brain Res 330:150-153.
366. Smart TG, Xie X, Krishek BJ. 1994. Modulation of inhibitory and excitatory amino acid receptor ion channels by zinc. Prog Neurobiol 42:393-441. (Pubitemid 24147654)
367. Smart TG, Hosie AM, Miller PS. 2004. Zn2+ ions: Modulators of excitatory and inhibitory synaptic activity. Neuroscientist 10:432-442.
368. Smith AP, Lee NM. 2007. Role of zinc in ALS. Amyotroph Lateral Scler 8:131-143.
369. Sowa-Kućma M, Legutko B, Szewczyk B, Novak K, Znojek P, Poleszak E, Papp M, Pilc A, Nowak G. 2008. Antidepressant-like activity of zinc: Further behavioral and molecular evidence. J Neural Transm 115:1621-1628.
370. Spahl DU, Berendji-Grün D, Suschek CV, Kolb-Bachofen V, Kröncke KD. 2003. Regulation of zinc homeostasis by inducible NO synthase-derived NO: Nuclear metallothionein translocation and intranuclear Zn2+ release. Proc Natl Acad Sci USA 100:13952-13957.
371. Sperk G. 2007. Changes in GABAA receptors in status epilepticus. Epilepsia 48(Suppl 8):11-13. (Pubitemid 350045512)
372. Sterman MB, Shouse MN, Fairchild MD. 1988. Zinc and seizure mechanisms. In: Morley JE, Sterman MB, Walsh JH, editors. Nutritional modulation of neural function. San Diego: Academic Press. p 307-319.
373. Stoltenberg M, Bush AI, Bach G, Smidt K, Larsen A, Rungby J, Lund S, Doering P, Danscher G. 2007. Amyloid plaques arise from zinc-enriched cortical layers in APP/PS1 transgenic mice and are paradoxically enlarged with dietary zinc deficiency. Neuroscience 150:357-369. (Pubitemid 350198720)
374. Suh SW, Jensen KB, Jensen MS, Silva DS, Kesslak PJ, Danscher G, Frederickson CJ. 2000. Histochemically-reactive zinc in amyloid plaques, angiopathy, and degenerating neurons of Alzheimer's diseased brains. Brain Res 852:274-278. (Pubitemid 30035163)
375. Suh SW, Jo SM, Vajda Z, Danscher G. 2001. Adrenalectomy causes loss of zinc ions in zinc-enriched (ZEN) terminals and decreases seizure-induced neuronal death. Brain Res 895:25-32. (Pubitemid 32231134)
376. Sunderman FW Jr. 1995. The influence of zinc on apoptosis. Ann Clin Lab Sci 25:134-142.
377. Suzuki J, Kasamo K, Ishida N, Murashima YL. 1991. Initiation, propagation and generalization of paroxysmal discharges in an epileptic mutant animal. Jpn J Psychiatry Neurol 45:271-274.
378. Swaminath G, Steenhuis J, Kobilka B, Lee TW. 2002. Allosteric modulation of beta2-adrenergic receptor by Zn(2+). Mol Pharmacol 61:65-72.
379. Takeda A. 2000. Movement of zinc and its functional significance in the brain. Brain Res Brain Res Rev 34:137-148.
380. Takeda A. 2001. Zinc homeostasis and functions of zinc in the brain. Biometals 14:343-351.
381. Takeda A, Hanajima T, Ijiro H, Ishige A, Iizuka S, Okada S, Oku N. 1999. Release of zinc from the brain of El (epilepsy) mice during seizure induction. Brain Res 828:174-178. (Pubitemid 29236489)
382. Takeda A, Hirate M, Tamano H, Oku N. 2003. Zinc movement in the brain under kainate-induced seizures. Epilepsy Res 54:123-129. (Pubitemid 36776730)
383. Takeda A, Fuke S, Ando M, Oku N. 2009. Positive modulation of long-term potentiation at hippocampal CA1 synapses by low micromolar concentrations of zinc. Neuroscience 158:585-591
384. Tapiero H, Tew KD. 2003. Trace elements in human physiology and pathology: Zinc and metallothioneins. Biomed Pharmacother 57:399-411. (Pubitemid 37498214)
385. Tassabehji NM, Corniola RS, Alshingiti A, Levenson CW. 2008. Zinc deficiency induces depression-like symptoms in adult rats. Physiol Behav 95:365-369.
386. Telford WG, Fraker PJ. 1995. Preferential induction of apoptosis in mouse CD4+CD8+ alpha beta TCRloCD3 epsilon lo thymocytes by zinc. J Cell Physiol 164:259-270.
387. Thompson CE, Markesbery WR, Ehmann WD, Mao YX, Vance DE. 1988. Regional brain trace element studies in Alzheimer's disease. Neurotoxicology 9:1-7.
388. Todorova MT, Burwell TJ, Seyfried TN. 1999. Environmental risk factors for multifactorial epilepsy in EL mice. Epilepsia 40:1697-1707.
389. Tønder N, Johansen FF, Frederickson CJ, Zimmer J, Diemer NH. 1990. Possible role of zinc in the selective degeneration of dentate hilar neurons after cerebral ischemia in the adult rat. Neurosci Lett 109:247-252. (Pubitemid 20056964)
390. Truong-Tran AQ, Ho LH, Chai F, Zalewski PD. 2000. Cellular zinc fluxes and the regulation of apoptosis/gene-directed cell death. J Nutr 130(5S Suppl):1459S-1466S. (Pubitemid 30244146)
391. Truong-Tran AQ, Carter J, Ruffin RE, Zalewski PD. 2001. The role of zinc in caspase activation and apoptotic cell death. Biometals 14:315-330. (Pubitemid 34066635)
392. Truong-Tran AQ, Ruffin RE, Foster PS, Koskinen AM, Coyle P, Philcox JC, Rofe AM, Zalewski PD. 2002. Altered zinc homeostasis and caspase-3 activity in murine allergic airway inflammation. Am J Respir Cell Mol Biol 27:286-296. (Pubitemid 34979286)
393. Tsuda M, Imaizumi K, Katayama T, Kitagawa K, Wanaka A, Tohyama M, Takagi T. 1997. Expression of zinc transporter gene. ZnT-1, is induced after transient forebrain ischemia in the gerbil. J Neurosci 17:6678-6684. (Pubitemid 27366620)
394. Tsuji S, Kobayashi H, Uchida Y, Ihara Y, Miyatake T. 1992. Molecular cloning of human growth inhibitory factor cDNA and its downregulation in Alzheimer's disease. EMBO J 11:4843-4850. (Pubitemid 23023427)
395. Uchibori M, Saito K, Yokoyama S, Sakamoto Y, Suzuki H, Tsuji T, Suzuki K. 2002. Foci identification of spike discharges in the EEGs of sleeping El mice based on the electric field model and wavelet decomposition of multi monopolar derivations. J Neurosci Methods 117:51-63. (Pubitemid 34669844)
396. Uchida Y. 1994. Growth-inhibitory factor, metallothionein-like protein, and neurodegenerative diseases. Biol Signals 3:211-215. (Pubitemid 24322046)
397. Uchida Y, Takio K, Titani K, Ihara Y, Tomonaga M. 1991. The growth inhibitory factor that is deficient in the Alzheimer's disease brain is a 68 amino acid metallothionein-like protein. Neuron 7:337-347.
398. Ueno S, Tsukamoto M, Hirano T, Kikuchi K, Yamada MK, Nishiyama N, Nagano T, Matsuki N, Ikegaya Y. 2002. Mossy fiber Zn2+ spillover modulates heterosynaptic N-methyl-D-aspartate receptor activity in hippocampal CA3 circuits. J Cell Biol 158:215-220.
399. Ugarte M, Osborne NN. 2001. Zinc in the retina. Progr Neurobiol 64:219-249.
400. Uki M, Narahashi T. 1996. Modulation of serotonin-induced currents by metals in mouse neuroblastoma cells. Arch Toxicol 70:652-660. (Pubitemid 26258633)
401. Vaidya VA, Siuciak JA, Du F, Duman RS. 1999. Hippocampal mossy fiber sprouting induced by chronic electroconvulsive seizures. Neuroscience 89:157-166. (Pubitemid 29049035)
402. Valente T, Auladell C. 2002. Developmental expression of ZnT3 in mouse brain: Correlation between the vesicular zinc transporter protein and chelatable vesicular zinc (CVZ) cells. Glial and neuronal CVZ cells interact. Mol Cell Neurosci 21:189-204.
403. Valente T, Auladell C, Pérez-Clausell J. 2002. Postnatal development of zinc-rich terminal fields in the brain of the rat. Exp Neurol 174:215-229. (Pubitemid 34293451)
404. Vallee BL, Auld DS. 1993. New perspective on zinc biochemistry: Cocatalytic sites in multi-zinc enzymes. Biochemistry 32:6493-6500.
405. Vallee BL, Falchuk KH. 1993. The biochemical basis of zinc physiology. Physiol Rev 73:79-118.
406. Vašák M. 2005. Advances in metallothionein structure and functions. J Trace Elem Med Biol 19:13-17.
407. Vašák M, Hasler DW. 2000. Metallothioneins-new structural and functional insights. Curr Opin Chem Biol 4:177-183.
408. Vela JM, Hidalgo J, González B, Castellano B. 1997. Induction of metallothionein in astrocytes and microglia in the spinal cord from the myelin-deficient jimpy mouse. Brain Res 767:345-355. (Pubitemid 27435782)
409. Vincent SR, Semba K. 1989. A heavy metal marker of the developing striatal mosaic. Brain Res Dev Brain Res 45:155-159. (Pubitemid 19019230)
410. Vogt K, Mellor J, Tong G, Nicoll R. 2000. The actions of synaptically released zinc at hippocampal mossy fiber synapses. Neuron 26:187-196. (Pubitemid 30947711)
411. Volk DW, Austin MC, Pierri JN, Sampson AR, Lewis DA. 2000. Decreased glutamic acid decarboxylase67 messenger RNA expression in a subset of prefrontal cortical gamma-aminobutyric acid neurons in subjects with schizophrenia. Arch Gen Psychiatry 57:237-245.
412. Vonk WI, Klomp LW. 2008. Role of transition metals in the pathogenesis of amyotrophic lateral sclerosis. Biochem Soc Trans 36(Part 6):1322-1328.
413. Vorobjev VS, Sharonova IN, Sergeeva OA, Haas HL. 2003. Modulation of ATP-induced currents by zinc in acutely isolated hypothalamic neurons of the rat. Br J Pharmacol 139:919-926.
414. Wang Y-X, Quastel DMJ. 1990. Multiple actions of zinc on transmitter release at mouse end-plates. Eur J Physiol 415:582-587.
415. Wätjen W, Benters J, Haase H, Schwede F, Jastorff B, Beyersmann D. 2001. Zn2+ and CD2+ increase the cyclic GMP level in PC12 cells by inhibition of the cyclic nucleotide phosphodiesterase. Toxicology 157:167-175. (Pubitemid 32115453)
416. Wätjen W, Haase H, Biagioli M, Beyersmann D. 2002. Induction of apoptosis in mammalian cells by cadmium and zinc. Environ Health Perspect 110(Suppl 5):865-867. (Pubitemid 35276883)
417. Weiss JH, Sensi SL. 2000. Ca2+-Zn2+ permeable AMPA or kainate receptors: Possible key factors in selective neurodegeneration. Trends Neurosci 23:365-371.
418. Weiss JH, Koh JY, Christine CW, Choi DW. 1989. Zinc and LTP. Nature 338:212.
419. Weiss JH, Hartley DM, Koh JY, Choi DW. 1993. AMPA receptor activation potentiates zinc neurotoxicity. Neuron 10:43-49.
420. Wengenack TM, Whelan S, Curran GL, Duff KE, Poduslo JF. 2000. Quantitative histological analysis of amyloid deposition in Alzheimer's double transgenic mouse brain. Neuroscience 101:939-944. (Pubitemid 30952917)
421. Wenzel HJ, Cole TB, Born DE, Schwartzkroin PA, Palmiter RD. 1997. Ultrastructural localization of zinc transporter-3 (ZnT-3) to synaptic vesicle membranes within mossy fiber boutons in the hippocampus of mouse and monkey. Proc Natl Acad Sci USA 94:12676-12681.
422. West AK, Stallings R, Hildebrand CE, Chiu R, Karin M, Richards RI. 1990. Human metallothionein genes: Structure of the functional locus at 16q13. Genomics 8:513-518.
423. White G, Gurley DA. 1995. Alpha subunits influence Zn block of gamma 2 containing GABAA receptor currents. Neuroreport 6:461-464.
424. Wildman SS, King BF, Burnstock G. 1998. Zn2+ modulation of ATP-responses at recombinant P2X2 receptors and its dependence on extracellular pH. Br J Pharmacol 123:1214-1220. (Pubitemid 28120521)
425. Wildman SS, Brown SG, Rahman M, Noel CA, Churchill L, Burnstock G, Unwin RJ, King BF. 2002. Sensitization by extracellular Ca(2+) of rat P2X(5) receptor and its pharmacological properties compared with rat P2X(1). Mol Pharmacol 62:957-966.
426. Wildman SS, Unwin RJ, King BF. 2003. Extended pharmacological profiles of rat P2Y2 and rat P2Y4 receptors and their sensitivity to extracellular H+ and Zn2+ ions. Br J Pharmacol 140:1177-1186.
427. Williamson A, Spencer D. 1995. Zinc reduces dentate granule cell hyperexcitability in epileptic humans. Neuroreport 6:1562-1564.
428. Williams RJ, Spencer JP, Goni FM, Rice-Evans CA. 2004. Zinc-histidine complex protects cultured cortical neurons against oxidative stress-induced damage. Neurosci Lett 371:106-110. (Pubitemid 39440754)
429. Woo TU, Walsh JP, Benes FM. 2004. Density of glutamic acid decarboxylase 67 messenger RNA-containing neurons that express the N-methyl-D-aspartate receptor subunit NR2A in the anterior cingulate cortex in schizophrenia and bipolar disorder. Arch Gen Psychiatry 61:649-657.
430. Woo TU, Shrestha K, Lamb D, Minns MM, Benes FM. 2008. N-methyl-D-aspartate receptor and calbindin-containing neurons in the anterior cingulate cortex in schizophrenia and bipolar disorder. Biol Psychiatry 64:803-809.
431. Xie X, Smart TG. 1991. A physiological role for endogenous zinc in rat hippocampal synaptic neurotransmission. Nature 349:521-524. (Pubitemid 21912095)
432. Xie X, Smart TG. 1994. Modulation of long-term potentiation in rat hippocampal pyramidal neurons by zinc. Pflugers Arch 427:481-486. (Pubitemid 24219030)
433. Xiong K, Peoples RW, Montgomery JP, Chiang Y, Stewart RR, Weight FF, Li C. 1999. Differential modulation by copper and zinc of P2X2 and P2X4 receptor function. J Neurophysiol 81:2088-2094.
434. Yin HZ, Sensi SL, Ogoshi F, Weiss JH. 2002. Blockade of Ca2+-permeable AMPA/kainate channels decreases oxygen-glucose deprivation-induced Zn2+ accumulation and neuronal loss in hippocampal pyramidal neurons. J Neurosci 22:1273-1279. (Pubitemid 34163729)
435. Yu WH, Lukiw WJ, Bergeron C, Niznik HB, Fraser PE. 2001. Metallothionein III is reduced in Alzheimer's disease. Brain Res 894:37-45. (Pubitemid 32197596)
436. Zago MP, Oteiza PI. 2001. The antioxidant properties of zinc: Interactions with iron and antioxidants. Free Radic Biol Med 31:266-274. (Pubitemid 32607594)
437. Zalewski PD, Forbes IJ, Betts WH. 1993. Correlation of apoptosis with change in intracellular labile Zn(II) using zinquin [(2-methyl- 8-p-toluenesulphonamido-6-quinolyloxy)acetic acid], a new specific fluorescent probe for Zn(II). Biochem J 296(Part 2):403-408.
438. Zhang N, Wei W, Mody I, Houser CR. 2007. Altered localization of GABA(A) receptor subunits on dentate granule cell dendrites influences tonic and phasic inhibition in a mouse model of epilepsy. J Neurosci 27:7520-7531. (Pubitemid 47066583)
439. Zhang LH, Wang X, Stoltenberg M, Danscher G, Huang L, Wang ZY. 2008. Abundant expression of zinc transporters in the amyloid plaques of Alzheimer's disease brain. Brain Res Bull 77:55-60.
440. Zheng H, Berman NE, Klaassen CD. 1995. Chemical modulation of metallothionein I and III mRNA in mouse brain. Neurochem Int 27:43-58.
441. Zirpel L, Parks TN. 2001. Zinc inhibition of group I mGluR-mediated calcium homeostasis in auditory neurons. J Assoc Res Otolaryngol 2:180-187. (Pubitemid 32622739)